Original Research

Published on 28 Apr 2022

From Fitting the Average to Fitting the Individual: A Cautionary Tale for Mathematical Modelers

in Cancer Immunity and Immunotherapy

Michael C. Luo
Elpiniki Nikolopoulou
Jana L. Gevertz

Frontiers in Oncology

doi 10.3389/fonc.2022.793908

1,752 views
10 citations

Review

Published on 27 Apr 2022

Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer

in Cancer Immunity and Immunotherapy

Ping Yang
Yingnan Qiao
Mei Meng
Quansheng Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.864159

6,113 views
11 citations

Original Research

Published on 27 Apr 2022

Construction of a Prognostic Model for Hypoxia-Related LncRNAs and Prediction of the Immune Landscape in the Digestive System Pan-Cancer

in Cancer Immunity and Immunotherapy

Zikang He
Hongfeng Liu
Huilin Guan
Jinli Ji
Ying Jiang
Naiwen Zhang
Zheyao Song
Xingyun Wang
Ping Shen
Huan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.812786

2,858 views
3 citations

Original Research

Published on 22 Apr 2022

Adiponectin Deficiency Enhances Anti-Tumor Immunity of CD8+ T Cells in Rhabdomyosarcoma Through Inhibiting STAT3 Activation

in Cancer Immunity and Immunotherapy

Jiao Peng
Haifeng Huang
Qiuchan Huan
Chenghui Liao
Zebin Guo
Die Hu
Xiangchun Shen
Haitao Xiao

Frontiers in Oncology

doi 10.3389/fonc.2022.847088

1,908 views
5 citations

Original Research

Published on 22 Apr 2022

Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From Toxoplasma gondii-Infected Dendritic Cells in Mice Colorectal Cancer

in Cancer Immunity and Immunotherapy

Shilan Zhu
Jinmiao Lu
Zhibing Lin
Asmaa M. I. Abuzeid
Xiaoyu Chen
Tingting Zhuang
Haiyan Gong
Rongsheng Mi
Yan Huang
Zhaoguo Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.870528

4,491 views
8 citations

Original Research

Published on 22 Apr 2022

DNA Hypermethylation-Regulated CX3CL1 Reducing T Cell Infiltration Indicates Poor Prognosis in Wilms Tumour

in Cancer Immunity and Immunotherapy

Tao Mi
Liming Jin
Zhaoxia Zhang
Jinkui Wang
Mujie Li
Chenghao Zhanghuang
Xiaojun Tan
Zhang Wang
Xiaomao Tian
Bin Xiang

Frontiers in Oncology

doi 10.3389/fonc.2022.882714

2,564 views
7 citations

Original Research

Published on 22 Apr 2022

Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models

in Cancer Immunity and Immunotherapy

Maria L. Lotsberg
Gro V. Røsland
Austin J. Rayford
Sissel E. Dyrstad
Camilla T. Ekanger
Ning Lu
Kirstine Frantz
Linda E. B. Stuhr
Henrik J. Ditzel
Jean Paul Thiery

Frontiers in Oncology

doi 10.3389/fonc.2022.818437

5,198 views
9 citations

Original Research

Published on 22 Apr 2022

Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy

in Cancer Immunity and Immunotherapy

Mohammad Fereydouni
Elnaz Ahani
Parth Desai
Mona Motaghed
Anthony Dellinger
Dean D. Metcalfe
Yuzhi Yin
Sung Hyun Lee
Tal Kafri
Aadra P. Bhatt

Frontiers in Oncology

doi 10.3389/fonc.2022.871390

4,107 views
15 citations

Original Research

Published on 21 Apr 2022

Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients

in Cancer Immunity and Immunotherapy

Chao Fang
Wenfeng Fang
Liqin Xu
Fangfang Gao
Yong Hou
Hua Zou
Yuxiang Ma
Janne Marie Moll
Yunpeng Yang
Dan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.837525

4,702 views
11 citations

Original Research

Published on 21 Apr 2022

Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features

in Cancer Immunity and Immunotherapy

Leidi Xu
Ning Chang
Tingyi Yang
Yuxiang Lang
Yong Zhang
Yinggang Che
Hangtian Xi
Weiqi Zhang
Qingtao Song
Ying Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.883543

2,278 views
2 citations

Original Research

Published on 21 Apr 2022

Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer

in Cancer Immunity and Immunotherapy

Chao Liu
Peiliang Wang
Yi Sun
Xue Dou
Xiaoyu Hu
Wenxue Zou
Yanlai Sun
Qinyong Hu
Jinbo Yue

Frontiers in Oncology

doi 10.3389/fonc.2022.756811

2,797 views
7 citations

Original Research

Published on 20 Apr 2022

ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma

in Cancer Immunity and Immunotherapy

Tingting Deng
Yang Liu
Jialang Zhuang
Yizhe Tang
Qin Huo

Frontiers in Oncology

doi 10.3389/fonc.2022.632042

4,238 views
9 citations

Review

Published on 19 Apr 2022

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

in Cancer Immunity and Immunotherapy

Amin Daei Sorkhabi
Aila Sarkesh
Hossein Saeedi
Faroogh Marofi
Mahnaz Ghaebi
Nicola Silvestris
Behzad Baradaran
Oronzo Brunetti

Frontiers in Oncology

doi 10.3389/fonc.2022.818447

3,719 views
11 citations

Mini Review

Published on 14 Apr 2022

LAG3-PD-1 Combo Overcome the Disadvantage of Drug Resistance

in Cancer Immunity and Immunotherapy

Yiming Wei
Zhaoming Li

Frontiers in Oncology

doi 10.3389/fonc.2022.831407

8,646 views
17 citations

Original Research

Published on 08 Apr 2022

Efficacy of Sorafenib Combined With Immunotherapy Following Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma: A Propensity Score Analysis

in Cancer Immunity and Immunotherapy

Jian Qin
Yusheng Huang
Hanjing Zhou
Shouhui Yi

Frontiers in Oncology

doi 10.3389/fonc.2022.807102

3,409 views
23 citations

Correction

Published on 07 Apr 2022

Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients

in Cancer Immunity and Immunotherapy

Xiaoxiang Rong
Jinyu Lv
Yantan Liu
Zhaojun Wang
Dongqiang Zeng
Yuedan Li
Shaowei Li
Jianhua Wu
Zheyu Shen
Min Shi

Frontiers in Oncology

doi 10.3389/fonc.2022.895938

1,475 views
1 citation

Navigation group

Articles

From Fitting the Average to Fitting the Individual: A Cautionary Tale for Mathematical Modelers

Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer

Construction of a Prognostic Model for Hypoxia-Related LncRNAs and Prediction of the Immune Landscape in the Digestive System Pan-Cancer

Adiponectin Deficiency Enhances Anti-Tumor Immunity of CD8+ T Cells in Rhabdomyosarcoma Through Inhibiting STAT3 Activation

Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From Toxoplasma gondii-Infected Dendritic Cells in Mice Colorectal Cancer

DNA Hypermethylation-Regulated CX3CL1 Reducing T Cell Infiltration Indicates Poor Prognosis in Wilms Tumour

Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models

Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy

Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients

Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features

Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer

ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

LAG3-PD-1 Combo Overcome the Disadvantage of Drug Resistance

Efficacy of Sorafenib Combined With Immunotherapy Following Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma: A Propensity Score Analysis

Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients